Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Interim Consolidated Balance Sheets

v3.20.2
Interim Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
CURRENT ASSETS:    
Cash and cash equivalents $ 9,059 $ 2,697
Other receivable and prepaid expenses 3,567 4,383
Short-term investment 78 64
Total current assets 12,704 7,144
NON-CURRENT ASSETS:    
Other non-current receivables 912
Operating lease right of use assets 66 82
Property, plant and equipment, net 30 36
Total long-term assets 96 1,030
Total assets 12,800 8,174
CURRENT LIABILITIES:    
Trade payables 437 2,156
Current maturity of operating lease liability 36 36
Deferred revenues 556 469
Other accounts payable 472 610
Total current liabilities 1,501 3,271
NON-CURRENT LIABILITIES:    
Long - term operating lease liability 22 39
Deferred revenues 2,121 2,422
Total long-term liabilities 2,143 2,461
CONTINGENT LIABILITIES AND COMMITMENTS
SHAREHOLDERS' EQUITY:    
Ordinary shares of NIS 0.25 par value - Authorized: 500,000,000 shares at June 30, 2020 and December 31, 2019; Issued and outstanding: 411,254,463 shares as of June 30, 2020; 120,652,683 shares as of December 31, 2019 29,234 8,225
Additional paid-in capital 98,056 103,401
Accumulated other comprehensive income 1,127 1,127
Accumulated deficit (119,261) (110,311)
Total equity 9,156 2,442
Total liabilities and shareholders' equity $ 12,800 $ 8,174